Invasive group A streptococcal disease surveillance in Canada, 2020.

Canada Streptococcus pyogenes antimicrobial resistance emm group A streptococcus iGAS surveillance

Journal

Canada communicable disease report = Releve des maladies transmissibles au Canada
ISSN: 1188-4169
Titre abrégé: Can Commun Dis Rep
Pays: Canada
ID NLM: 9303729

Informations de publication

Date de publication:
01 Sep 2022
Historique:
medline: 1 9 2022
pubmed: 1 9 2022
entrez: 18 12 2023
Statut: epublish

Résumé

Invasive group A streptococcal (iGAS) disease (caused by The Public Health Agency of Canada's National Microbiology Laboratory (Winnipeg, Manitoba) collaborates with provincial and territorial public health laboratories to conduct national surveillance of invasive Overall, the incidence of iGAS disease in Canada has increased from 4.0 to 8.1 cases per 100,000 population from 2009 to 2019. The 2019 incidence represents a slight decrease from the 2018 rate of 8.6 cases per 100,000 population. A total of 2,867 invasive Though the number of collected invasive

Sections du résumé

Background UNASSIGNED
Invasive group A streptococcal (iGAS) disease (caused by
Methods UNASSIGNED
The Public Health Agency of Canada's National Microbiology Laboratory (Winnipeg, Manitoba) collaborates with provincial and territorial public health laboratories to conduct national surveillance of invasive
Results UNASSIGNED
Overall, the incidence of iGAS disease in Canada has increased from 4.0 to 8.1 cases per 100,000 population from 2009 to 2019. The 2019 incidence represents a slight decrease from the 2018 rate of 8.6 cases per 100,000 population. A total of 2,867 invasive
Conclusion UNASSIGNED
Though the number of collected invasive

Identifiants

PMID: 38106647 PMC: PMC10723789
pubmed: 38106647
pii: 480905
pmc: PMC10723789

Types de publication

Journal Article

Langues

eng

Pagination

407-414

Déclaration de conflit d'intérêts

Competing interests None.

Auteurs

Alyssa Golden (A)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

Averil Griffith (A)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

Walter Demczuk (W)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

Gregory Tyrrell (G)

Provincial Laboratory for Public Health (Microbiology), Edmonton, AB.

Julianne Kus (J)

Public Health Ontario, Toronto, ON.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON.

Allison McGeer (A)

Toronto Invasive Bacterial Diseases Network (TIBDN), Department of Microbiology, Mount Sinai Hospital, Toronto, ON.

Marc-Christian Domingo (MC)

Laboratoire de santé publique du Québec, Institut national de santé publique du Québec, Sainte-Anne-de- Bellevue, QC.

Linda Hoang (L)

British Columbia Centre for Disease Control, Vancouver, BC.

Jessica Minion (J)

Roy Romanow Provincial Laboratory, Regina, SK.

Paul Van Caeseele (P)

Cadham Provincial Laboratory, Winnipeg, MB.

Hanan Smadi (H)

New Brunswick Department of Health, Fredericton, NB.

David Haldane (D)

Queen Elizabeth II Health Science Centre, Halifax, NS.

George Zahariadis (G)

Newfoundland and Labrador Public Health Laboratory, St. John's, NL.

Kristen Mead (K)

Queen Elizabeth Hospital, Charlottetown, PE.

Laura Steven (L)

Stanton Territorial Hospital Laboratory, Yellowknife, NT.

Lori Strudwick (L)

Yukon Communicable Disease Control, Whitehorse, YT.

Anita Li (A)

Centre for Immunization & Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON.

Michael Mulvey (M)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.
Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB.

Irene Martin (I)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

Classifications MeSH